Boobis AR - Search Results

1

Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Speirs CJ, Murray S, Davies DS, Biola Mabadeje AF, Boobis AR. Speirs CJ, et al. Among authors: boobis ar. Br J Clin Pharmacol. 1990 Jan;29(1):101-9. doi: 10.1111/j.1365-2125.1990.tb03608.x. Br J Clin Pharmacol. 1990. PMID: 2153391 Free PMC article.

2

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS. Sesardic D, et al. Among authors: boobis ar. Br J Clin Pharmacol. 1990 Jun;29(6):651-63. doi: 10.1111/j.1365-2125.1990.tb03686.x. Br J Clin Pharmacol. 1990. PMID: 2378786 Free PMC article.

3

The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.

Kobayashi S, Murray S, Watson D, Sesardic D, Davies DS, Boobis AR. Kobayashi S, et al. Among authors: boobis ar. Biochem Pharmacol. 1989 Sep 1;38(17):2795-9. doi: 10.1016/0006-2952(89)90433-4. Biochem Pharmacol. 1989. PMID: 2775304

4

A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

Sesardic D, Boobis AR, Edwards RJ, Davies DS. Sesardic D, et al. Among authors: boobis ar. Br J Clin Pharmacol. 1988 Oct;26(4):363-72. doi: 10.1111/j.1365-2125.1988.tb03393.x. Br J Clin Pharmacol. 1988. PMID: 3190986 Free PMC article.

5

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.

Speirs CJ, Murray S, Boobis AR, Seddon CE, Davies DS. Speirs CJ, et al. Among authors: boobis ar. Br J Clin Pharmacol. 1986 Dec;22(6):739-43. doi: 10.1111/j.1365-2125.1986.tb02969.x. Br J Clin Pharmacol. 1986. PMID: 3567021 Free PMC article.

6

Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.

Davies DS, Kahn GC, Murray S, Brodie MJ, Boobis AR. Davies DS, et al. Among authors: boobis ar. Br J Clin Pharmacol. 1981 Jan;11(1):89-91. doi: 10.1111/j.1365-2125.1981.tb01108.x. Br J Clin Pharmacol. 1981. PMID: 7213514 Free PMC article. No abstract available.

7

Heterocyclic amines: evaluation of their role in diet associated human cancer.

Gooderham NJ, Murray S, Lynch AM, Edwards RJ, Yadollahi-Farsani M, Bratt C, Rich KJ, Zhao K, Murray BP, Bhadresa S, Crosbie SJ, Boobis AR, Davies DS. Gooderham NJ, et al. Among authors: boobis ar. Br J Clin Pharmacol. 1996 Jul;42(1):91-8. doi: 10.1046/j.1365-2125.1996.37513.x. Br J Clin Pharmacol. 1996. PMID: 8807149 Free PMC article. Review.

8

Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Boobis AR, Davies DS. Boobis AR, et al. Br J Clin Pharmacol. 1990 Oct;30(4):653-6. doi: 10.1111/j.1365-2125.1990.tb03832.x. Br J Clin Pharmacol. 1990. PMID: 2291880 Free PMC article. No abstract available.

9

High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat.

Sesardic D, Edwards RJ, Davies DS, Thomas PE, Levin W, Boobis AR. Sesardic D, et al. Among authors: boobis ar. Biochem Pharmacol. 1990 Feb 1;39(3):489-98. doi: 10.1016/0006-2952(90)90055-p. Biochem Pharmacol. 1990. PMID: 2306261

10

The inducibility and catalytic activity of cytochromes P450c (P450IA1) and P450d (P450IA2) in rat tissues.

Sesardic D, Cole KJ, Edwards RJ, Davies DS, Thomas PE, Levin W, Boobis AR. Sesardic D, et al. Among authors: boobis ar. Biochem Pharmacol. 1990 Feb 1;39(3):499-506. doi: 10.1016/0006-2952(90)90056-q. Biochem Pharmacol. 1990. PMID: 2306262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page